20 completed, 11 unknown, 7 terminated, 3 withdrawn. 14 Phase 3, 11 Phase 2, 10 Not applicable, 6 Phase 1, 4 Phase 4.
Follow DHEA: new trials by email Literature Review of DHEA trials Research Report on DHEA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial Pregnenolone, DHEA, Placebo - Chronic Low Back Pain | Phase 2 | Not yet recruiting | VA Office of Research and Development | 108 | 2026-12-01 | 2026-09-08 |
| Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer Biospecimen Collection, Prasterone, Survey Administration - Anal Carcinoma, Cervical Carcinoma | Phase 2 | Recruiting | Ohio State University Comprehensive Cancer Center | 25 | 2026-03-12 | 2026-04-21 |
| The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders myo-inositol, Somatropin, Dehydroepiandrosterone - Poor Responders | Phase 2 / Phase 3 | Unknown | Beni-Suef University | 300 | 2023-07-30 | 2023-07-18 |
| Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women Exercise, DHEA - Low Bone Density, Osteoporosis | Not applicable | Completed | University of Colorado, Denver | 41 | 2022-03-11 | 2024-12-10 |
| Effectiveness of Adjuvant Supplements Prior to in IVF DHEA, DHEA+CoQ10+Tocotrienol - Dietary Supplements | Not applicable | Completed | Kaohsiung Veterans General Hospital. | 70 | 2022-03-02 | 2024-08-02 |
| Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women Prasterone, Placebo - Recurrent Urinary Tract Infection, Postmenopause | Phase 3 | Withdrawn | Olivia Cardenas-Trowers, M.D. | 2020-05-01 | 2021-06-30 | |
| Neurosteroids in PTSD - Biomarkers to Therapeutics DHEA - Posttraumatic Stress Disorder | Phase 2 | Terminated | VA Office of Research and Development | 5 | 2019-07-08 | 2023-05-06 |
| Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy Intrarosa, Placebos - Menopause, Genitourinary Syndrome of Menopause | Phase 3 | Unknown | Center for Vulvovaginal Disorders | 40 | 2019-03-02 | 2019-01-31 |
| DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women DHEA, Placebo, Exercise - Low Bone Mass, Osteoporosis, Postmenopausal | Not applicable | Completed | University of Colorado, Denver | 152 | 2018-02-12 | 2024-12-05 |
| The Effects of Fluoxetine and/or DHEA Placebo Oral Tablet, Fluoxetine, DHEA - Type 1 Diabetes Mellitus | Early Phase 1 | Recruiting | University of Maryland, Baltimore | 60 | 2017-12-19 | 2025-10-06 |
| DHEA in Synovial Sarcoma Patients DHEA, FACT-67 validated survey - Synovial Sarcoma, Sarcoma, Synovial | Phase 1 | Terminated | Washington University School of Medicine | 11 | 2016-09-13 | 2019-09-09 |
| Combined Dehydropeiandrosterone and Growth Hormone in Women With Expected Poor Ovarian Response Undergoing ICSI DHEA, Growth hormone, Placebo 1 - Subfertility | Phase 4 | Unknown | Cairo University | 230 | 2016-06-01 | 2018-01-03 |
| Dehydroepiandrosterone Versus Growth Hormone in Women Undergoing ICSI With Expected Poor Ovarian Response DHEA, Growth Hormone-Releasing Hormone, Placebo 1 - Subfertility | Phase 3 | Unknown | Cairo University | 210 | 2016-06-01 | 2016-07-06 |
| DHEA Versus Placebo in Women With Poor Ovarian Response DHEA, Placebo - Subfertility | Phase 3 | Unknown | Cairo University | 440 | 2015-10-01 | 2016-07-06 |
| Testosterone Gel in Poor Responders Undergoing IVF Testosterone gel, DHEA - Infertility | Not applicable | Withdrawn | Vietnam National University | 2015-09-01 | 2017-04-18 | |
| Effect of DHEA on Patients With Poor Ovarian Responds Dehydroepiandrosterone, placebo(medical starch) - Subfertility | Not applicable | Unknown | The Affiliated Hospital of Inner Mongolia Medical University | 350 | 2015-02-01 | 2023-07-20 |
| Dehydroepiandrosterone (DHEA)Supplementation Pre-IVF(In Vitro Fertilization) Cycles DHEA - Infertility | Phase 4 | Completed | ShangHai Ji Ai Genetics & IVF Institute | 78 | 2014-12-01 | 2019-09-19 |
| Administration of DHEA in Patients With Poor Response to Ovarian Stimulation for IVF gonadotropins plus DHEA, Gonadotropins - Efficacy of DHEA, Pregnancy Rate | Phase 2 / Phase 3 | Unknown | University of Athens | 50 | 2014-10-01 | 2014-09-10 |
| Assess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve DHEA, Another Androgenic Agent (VRaA), Fixed combination of 2 androgenic agents (VR2A) - Healthy Women, Infertility, Female | Phase 1 | Completed | Laboratorios Andromaco S.A. | 94 | 2014-07-15 | 2019-05-29 |
| Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response? DHEA - Subfertility | Phase 3 | Completed | Cairo University | 140 | 2014-05-01 | 2015-05-19 |
Showing 20 of 44. Sign in to see all of them.
Infertility (8) · Primary Ovarian Insufficiency (4) · Atrophic Vaginitis (3) · Breast Neoplasms (2) · Diabetes Mellitus, Type 1 (2) · Infertility, Female (2) · Osteoporosis (2) · Anus Neoplasms (1) · Bone Diseases, Metabolic (1) · Breast Neoplasms, Male (1) · Dyspareunia (1) · Erectile Dysfunction (1) · Fatigue (1) · Frailty (1) · HIV Infections (1)
Cairo University (4) · EndoCeutics Inc. (3) · Center for Human Reproduction (2) · National Institute on Aging (NIA) (2) · University of Colorado, Denver (2) · University of Maryland, Baltimore (2) · VA Office of Research and Development (2) · Washington University School of Medicine (2) · Barbara Ann Karmanos Cancer Institute (1) · Beni-Suef University (1) · CHU de Quebec-Universite Laval (1) · Center for Vulvovaginal Disorders (1) · Chinese Medical Association (1) · David H. Barad (1) · Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (1)
United States (25) · Canada (5) · Egypt (5) · China (2) · Australia (1) · Chile (1) · Finland (1) · Israel (1) · Italy (1) · Taiwan (1) · Vietnam (1)
Norbert Gleicher, MD (3) · Catherine Jankowski, PhD (2) · David Barad, MD, MS (2) · David F Archer, MD (2) · AbdelGany M Hassan (1) · Allison M Quick, MD (1) · Alvaro Morales, MD FRCSC (1) · Anne Kenny, MD (1) · Brian A Van Tine, M.D., Ph.D. (1) · Christine E. Marx, MD MA (1) · Cusan Leonello, MD Ph D (1) · David Archer, MD (1) · David H Barad, MD, MS (1) · Dennis T Villareal, MD (1)
PMID 25968836, PMID 15536111, PMID 26972555, PMID 16735495, PMID 16997936, PMID 17665393, PMID 18071895, PMID 18598765, PMID 18812486, PMID 19811650, PMID 20191499, PMID 20638339, PMID 20729538, PMID 20863330, PMID 22835219, PMID 23084789, PMID 23144466, PMID 23212832, PMID 23664458, PMID 23954500, PMID 24004296, PMID 24796766, PMID 24932478, PMID 25395742, PMID 25511551, PMID 25734980, PMID 25771041, PMID 26509785, PMID 26725467, PMID 26963897, PMID 27997350, PMID 30591548
K23RR016191 (2), 1IK2CX001397-01A2 (1), I01CX002667 (1), M01RR000036 (1), P01AG014383 (1), P30CA022453 (1), P30CA069533 (1), P30DK056341 (1), P60AG013629 (1), P60DK020579 (1), R01AG020076 (1), R01AG053489 (1), R01AR077924 (1), R01DK069803 (1), R21CA119598 (1)